Fat mass and obesity (FTO) and melanocortin-4 receptor (MC4R) and are relevant genes associated with obesity. This could be through food intake, but results are contradictory. Modulation by diet or other lifestyle factors is also not well understood.
To investigate whether MC4R and FTO associations with body-weight are modulated by diet and physical activity (PA), and to study their association with alcohol and food intake.
Adherence to Mediterranean diet (AdMedDiet) and physical activity (PA) were assessed by validated questionnaires in 7,052 high cardiovascular risk subjects. MC4R rs17782313 and FTO rs9939609 were determined. Independent and joint associations (aggregate genetic score) as well as statistical and biological gene-lifestyle interactions were analyzed.
FTO rs9939609 was associated with higher body mass index (BMI), waist circumference (WC) and obesity (P<0.05 for all). A similar, but not significant trend was found for MC4R rs17782313. Their additive effects (aggregate score) were significant and we observed a 7% per-allele increase of being obese (OR = 1.07; 95%CI 1.01–1.13). We found relevant statistical interactions (P<0.05) with PA. So, in active individuals, the associations with higher BMI, WC or obesity were not detected. A biological (non-statistical) interaction between AdMedDiet and rs9939609 and the aggregate score was found. Greater AdMedDiet in individuals carrying 4 or 3-risk alleles counterbalanced their genetic predisposition, exhibiting similar BMI (P = 0.502) than individuals with no risk alleles and lower AdMedDiet. They also had lower BMI (P = 0.021) than their counterparts with low AdMedDiet. We did not find any consistent association with energy or macronutrients, but found a novel association between these polymorphisms and lower alcohol consumption in variant-allele carriers (B+/−SE: −0.57+/−0.16 g/d per-score-allele; P = 0.001).
Citation: Corella D, Ortega-Azorín C, Sorlí JV, Covas MI, Carrasco P, Salas-Salvadó J, et al. (2012) Statistical and Biological Gene-Lifestyle Interactions of MC4R and FTO with Diet and Physical Activity on Obesity: New Effects on Alcohol Consumption. PLoS ONE 7(12): e52344. https://doi.org/10.1371/journal.pone.0052344
Editor: Kaberi Dasgupta, McGill University, Canada
Received: August 1, 2012; Accepted: November 12, 2012; Published: December 21, 2012
Copyright: © 2012 Corella et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The Official funding agency for Biomedical Research of the Spanish Government, Instituto de Salud Carlos III (ISCIII) and Fondo Europeo de Desarrollo Regional (FEDER), provided the grants for his study: RTIC G03/140, CIBERobn, RD 06/0045, PI04-2239, PI 05/2584, CP06/00100, PI07/0240, PI07/1138, PI07/0954, PI 07/0473, PI10/01407, PI11/02505 PI11/01647 CNIC-06 and AGL2010-22319-C03-03. The Generalitat Valenciana provided grants AP-042/11 and BEST11-263. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interest exist.
Early prediction of obesity risk will be facilitated by the identification of the main genes and their relevant genetic variants. However, the next step involving more successful obesity prevention and therapy will better achieve after learning how the phenotypic expression of the relevant genetic variants are modulated by pertinent lifestyle factors such as dietary intake and physical activity in order to reduce the manifestation of obesity in genetically predisposed individuals. Outstanding among the many genes associated with obesity is the fat mass and obesity gene (FTO). It was the first locus discovered to be associated with BMI and obesity risk . One year after, a meta-analysis of several genome wide association studies GWAs , established that the second most important locus associated with BMI was the melanocortin-4 receptor gene (MC4R). Previous studies had already identified various rare mutations in the MC4R as the commonest cause of monogenic forms of early-onset obesity , . Of the various polymorphisms found both in the FTO and in the MC4R loci, the most significant are rs9939609 and rs17782313, respectively , , . The minor allele of the rs9939609 (C>A), has been consistently associated with higher BMI and obesity risk , –. In a meta-analysis of population-based studies , the per-A allele odds ratio (OR) for obesity was 1.31 [95% confidence interval (CI): 1.23–1.39]. Although the minor allele of the rs17782313 (T>C), has also been significantly associated with greater BMI , , –, its relevance in terms of the magnitude of the association is considered smaller than that of FTO polymorphism, being the per-allele OR for obesity of 1.12 (95% CI: 1.08–1.16) in the initial meta-analysis . A few studies have also jointly analyzed the FTO and MC4R polymorphisms, describing their additive effects on obesity related variables , , , . Thus in a European population, Cauchi et al  found that, compared to participants carrying neither FTO nor MC4R risk allele, subjects with three or four risk alleles had a 1.8-fold increased obesity risk.
The mechanism by which these polymorphisms may be associated with greater BMI is unknown, but some studies on animals have suggested that for both of them it could be through a higher food intake –. However, human studies investigating the associations of these polymorphisms with dietary intake are scarce and contradictory –. Although initial studies – have reported that FTO polymorphisms were associated with higher fat and energy intake in carriers of the variant alleles, other studies have not been able to replicate these associations –. Studies on the MC4R locus are few and also divergent –, requiring more research. Likewise, whereas several studies have found an important statistical interaction with physical activity for the FTO locus, so that greater physical activity attenuates the increasing effects of the A-allele on BMI –, for the MC4R polymorphism there are hardly any studies that have analyzed this interaction , .
Although recently several studies analyzed the possible modulation of the effects of the FTO polymorphisms on BMI through diet, the results are still differing , –. This, and the lack of studies focused on gene-diet interactions of the MC4R polymorphism, make it necessary to carry out new research on these gene-diet interactions considering both loci jointly. Moreover, although the vast majority of studies have focused on statistical interactions , , we also have the so-called “biological interactions” in which environmental factors could modify genetic susceptibility without the interaction term in the mathematical model being statistically significant –. Hence our aims were: 1) To analyze the associations of the MC4R rs17782313 and FTO rs9939609 polymorphisms with BMI and their modulation by physical activity and diet, including the overall adherence to the Mediterranean diet (MedDiet) pattern; 2) To study whether these polymorphisms have an influence on food and alcohol intake in a high cardiovascular risk population.
We included 7,052 participants (3,008 men and 4,044 women) from the PREDIMED (PREvención con DIeta MEDiterránea) study from whom DNA was isolated, the FTO polymorphism (rs9939609) determined, and who had valid data for the main clinical and lifestyle variables analyzed at baseline. In 7,019 of them, the MC4R rs17782313 polymorphism was successfully determined. The PREDIMED study is a multi-center clinical trial (controlled-trials.com number, ISRCTN35739639) aimed at assessing the effects of the MedDiet on the primary prevention of cardiovascular disease . The 7,052 participants analyzed here did not differ in the main characteristics from those of the total cohort (n = 7,447). Details of the PREDIMED Study have been fully described elsewhere . Briefly, from October 2003 potential high cardiovascular risk subjects were selected by physicians in Primary Care Centers. Eligible subjects were community-dwelling people (55–80 years of age for men; 60–80 years of age for women) who fulfilled at least one of two criteria: Type 2 diabetes; 3 or more cardiovascular risk factors (hypertension, dyslipidemia, body mass index [BMI] ≥25 kg/m2, current smoking, or a family history of premature cardiovascular disease). The specific cut-off points for these eligibility criteria have been previously described . Type 2 diabetes was diagnosed according to American Diabetes Association criteria . Exclusion criteria included a personal history of cardiovascular disease, any severe chronic illness, and drug or alcohol addiction . Participants were randomly assigned to three interventions . In this study we analyzed data at baseline. The Institutional Review Board/Ethics Committee of each participating center (University of Valencia, Valencia; Municipal Institut for Medical Research, Barcelona; University Rovira i Virgili, Reus; University of Navarra, Pamplona; Hospital Primary Care Division of Sevilla, San Pablo Health Center, Sevilla; University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria; University of Barcelona, Barcelona; University of Malaga; Málaga; Hospital Son Dureta, Palma de Mallorca; Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona and Institut d’Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Hospital Clinic, Barcelona, Spain) approved the study protocol. All participants provided written informed consent.
Demographic, Clinical, Anthropometric and Dietary Measurements
The baseline examination included assessment of standard cardiovascular risk factors, medication use, socio-demographic factors and lifestyle variables, as previously detailed . Food intake and alcoholic beverage consumption, including wine, beer, and spirits, were assessed through a validated semi-quantitative 137-item food frequency questionnaire . Energy and nutrient intake were calculated from Spanish food composition tables . We calculated alcohol intake (g/d) for each individual on the basis of the type and amount of alcoholic beverages by multiplying the amount of the beverage (mL) by the respective grade (% alcohol) and the constant 0.80 to transform alcohol volumes into weight. In addition, three groups of alcohol consumption were defined according to the reported daily intake of alcohol: no intake (0 g/d), moderate intake (<26.4 g/d for men and <13.2 g/d for women), and high intake (26.4 g/d for men and 13.2 g/d for women). These gram amounts correspond to 1 drink/d for women and 2 drinks/d for men .
The baseline examination also included the administration of a validated 14-item questionnaire indicating the degree of adherence to the traditional MedDiet . This screener consists of 14 questions on food consumption frequency and on food intake habits considered characteristic of the Spanish MedDiet. Each question was scored 0 or 1. The final score ranged from 0 to 14. The greater the score obtained from the questionnaire, the greater the adherence to the MedDiet. Dichotomous variables of adherence to the MedDiet and nutrient intake were created using as cut-off points the sample means. Physical activity was estimated by the Minnesota Leisure Time Physical Activity Questionnaire, validated for its use in Spanish subjects , .
Weight and height were measured with calibrated scales and a wall-mounted stadiometer, respectively. BMI was calculated as weight in kilograms divided by the square of height in meters.
DNA Extraction and Genotyping
At baseline, blood samples were obtained from each participant after an overnight fast and were frozen at −80°C and shipped to central laboratories for analyses . Genomic DNA was extracted from buffy-coat with the MagNaPure LC DNA Isolation Kit (Roche Diagnostics, Mannheim, Germany). The MC4R rs17782313 and FTO rs9939609 polymorphisms were genotyped on a 7900HT Sequence Detection System (Applied Biosystems, FosterCity, CA, USA) using fluorescent allelic discrimination TaqManTM assays. The calling rate for both polymorphisms was >95%. For quality control purposes, 5% of samples were randomly selected samples and genotyped a second time. There were no discrepancies between the two results.
Chi-square tests were used to test differences between observed and expected genotype frequencies, assuming Hardy–Weinberg equilibrium, and to test differences in percentages. Genetic variables were tested using co-dominant models of the polymorphisms individually. In addition, an additive genetic score was created from the FTO and the MC4R polymorphism so that the presence of each of variant allele for each polymorphism was scored as one point according to the work of Cauchi et al . The range of values of this aggregate score variable was from 0 (homozygous subjects for non-variant alleles) to 4 points (homozygous subjects for the variant alleles both at the FTO and MC4R genes). In addition, due to the low prevalence of homozygous subjects for the variant alleles, a grouped score variable was created grouping the categories of 3 and 4 points as previously described . We used t and ANOVA tests to compare crude means of obesity indexes across genetic categories. Multivariate adjustments for comparisons of continuous variables were carried out by generalized linear models. Models were first adjusted for age, sex, center and diabetes. Additional adjustments for energy intake, physical activity, adherence to the MedDiet or BMI were also carried out as indicated. In addition to the categorical analysis, the FTO and the MC4R polymorphism were considered in the co-dominant model as linear terms coded 0, 1, or 2 (additive effect), depending of the number of variant alleles with the homozygote wild-type coded as 0. The regression coefficient (B) and the 95% confidence interval (CI) was estimated for each polymorphism. This coefficient indicates the change of Y for each variant allele of the tested polymorphism. Likewise, the aggregate score was also considered as a linear term coded as 0, 1, 2, 3, or 4 depending on the number of variant alleles. The corresponding B and 95%CI for the aggregate score was also estimated in the unadjusted and adjusted regression models.
Dichotomous variables for dietary variables and physical activity were created using as cut-off the sample means. Alcohol intake was square-root transformed for statistical testing. Logistic regression methods were also used to estimate the associations of the MC4R rs17782313 and FTO rs9939609 polymorphisms to predict obesity prevalence and to adjust for confounders as indicated. In addition to the categorical analysis, the FTO and the MC4R polymorphism were considered in the co-dominant model as linear terms coded 0, 1, or 2 (allele dosage effect), depending of the number of variant alleles with the homozygote wild-type coded as 0. The regression coefficient (B) and the 95% confidence interval (CI) was estimated for each polymorphism. This coefficient indicates the change of Y for each variant allele of the tested polymorphism. Likewise, the aggregate score was also considered as a linear term coded as 0, 1, 2, 3, or 4 depending on the number of variant alleles. The corresponding B and 95%CI for the aggregate score were also estimated in the unadjusted and adjusted regression models.
The homogeneity of the effects by sex was also statistically tested using the likelihood ratio test. To test the interaction between the MC4R rs17782313, the FTO rs9939609 polymorphisms or their score variable and physical activity, adherence to MedDiet or the other dietary variables, separated multivariate regression models including the corresponding main effects and interaction terms in addition to the potential confounders, were fitted. The likelihood ratio test was used to obtain the P values for interactions. Stratified analyses were also carried out. Statistical analyses were performed with the SPSS package, version 15.0 (SPSS, Chicago, IL). All tests were two-tailed and P values <0.05 were considered statistically significant.
Power calculations were performed using QUANTO software, v.1.2.4  and Power and Sample Size Calculation (biostat.mc.vanderbilt.edu/wiki/Main/PowerSampleSize). Initial sample size estimations were undertaken assuming an allele frequency for the minor FTO and MC4r alleles of 0.43 and of 0.23, respectively and the parameters from the meta-analysis by Frayling et al  for the FTO (a 31% per-allele increase in the odds of being obese) and the parameters from the meta-analysis by Loos et al  for the MC4R (a 12% per-allele increase in the odds of being obese), respectively. To detect these reported effects our sample size (n = 7,019) had a power higher that 80% (alpha-level = 0.05). Our study was adequately powered (>80%) to detect as statistically significant a 7% per-allele increase in the OR for obesity for the additive effects of both polymorphism in the aggregate score in the population as a whole. The power to detect a statistically significant gene-environment interaction effect higher than OR 1.20 in the logistic regression model (using a dichotomous environmental variable based on the population mean) was >95% for the FTO (additive effects) and >80% for the MC4R. However, as the gene-interaction effect of the MC4R was 1.10, the power to detect this interaction as statistically significant was <50%. For the aggregate score, the power to detect the above described additive gene-environment interaction effects in determining obesity was >80%. For power calculation in the linear regression analysis, we considered the magnitude of the gene-environment interaction, and according to Luan et al  an interaction was considered to be relevant in magnitude when the ratio of the two regression slopes [B1 for the genetic variable as additive in the first versus the second (B2) stratum was at least 2]. With a sample size of 7019 individuals our study has a power>80% to detect this interaction effect for the different outcomes analyzed. Finally, this number of study subjects allowed us a power>90% to detect as statistically significant mean differences of dietary intake by genotype based on previously reported significant studies –, .
Table 1 shows demographic, clinical, lifestyle and genetic characteristics of the 7,052 participants in the PREDIMED study at baseline depending on the FTO rs9939609 and the MC4R rs17782313 polymorphisms. Because of the selection criteria, the prevalence of obesity was high (46.8%). The mean (±SD) of adherence to the MedDiet was 9±2 points on the scale of 0 to 14 points in the whole populations. Genotype frequencies did not deviate from Hardy-Weinberg equilibrium expectations for either polymorphisms (P = 0.709 for the FTO rs9939609 and P = 0.637 for the MC4R rs17782313). The aggregate score of the two polymorphisms had a prevalence of 20.6% for zero points (homozygous subjects for non-variant alleles); 40.9% for 1 point (subjects with one variant allele either at FTO or MC4R; 29.2% for 2 points (subjects with two variant alleles), 8.5% for 3 points (subjects with 3 variant alleles) and 0.8% for 4 points (homozygous subjects for the variant alleles both at the FTO and MC4R genes). As the number of subjects with a score of 4 points was very low, a new score-grouped variable was created grouping the categories of 3 and 4 points.
Association between the FTO rs9939609 and MC4R rs17782313 Polymorphisms and Anthropometric Variables at Baseline
On analyzing the population as a whole we found a statistically significant association between the FTO polymorphism and body-weight, BMI and waist circumference so that carriers of the variant allele (A) presented statistically significant higher mean values than homozygous subjects for the major allele (Table 2). These associations were statistically significant in the unadjusted analysis and remained statistically significant even after multivariate control for sex, age, center, diabetes, total energy intake and physical activity (fully adjusted model). The regression coefficient (B), assuming additive effects of the variant allele of FTO were also statistically significant for body-weight, BMI and waist circumference. For BMI, we observed an increase of 0.17 kg/m2 (95%CI: 0.05–0.30) for each additional variant allele. This increase, although statistically significant was not clinically relevant. On stratifying by sex (data not shown), this association was of greater magnitude in women than in men. However, the interaction terms between the FTO polymorphism and sex did not reach statistical significance for any of the anthropometric measurements analyzed (P>0.05 for all of them). With regard to the MC4R polymorphism, its association with BMI and waist circumference was of lower magnitude than for FTO. Although a trend was observed for greater values of BMI and waist circumference in homozygous subjects for the variant allele (C-allele), statistical significance was not reached in the total population (Table 2). However, we obtained statistically significant results for body-weight (0.60 kg per-variant allele; 95% CI: 0.17–1.03) and for height (0.3 cm per-variant allele; 95%CI: 0.01–0.05) in the adjusted analysis. Although subjects carrying variant alleles for the MC4R polymorphism were also significantly taller (P = 0.031) than their counterparts, the magnitude of the effect was very small. On analyzing the effects of these polymorphisms on obesity we found similar results (Table 2). The FTO polymorphism was significantly associated with a higher prevalence of obesity (a 10% per-allele increase in the odds of being obese; 95%CI: 2%–17%). Homozygous subjects with the variant FTO allele conclusively demonstrated a 20% higher risk for obesity (model adjusted for sex, age, center, diabetes, total energy intake, and physical activity; OR 1.20, 95% CI 1.04–1.38). There was a suggestion that homozygous subjects with the variant M4CR allele had a 12% higher risk for obesity but this finding was not conclusive (OR: 1.12, 95% CI 0.89–1.41). Although our study was adequately powered to detect the effect reported by Loos et al  for the MC4R, as finally the magnitude of the effect in our population was lower than that initially expected, our study was unpowered (<80%) to detect as statistically significant the small effect found for the MC4R in the whole population.
On creating the aggregate score variable for the two polymorphisms, we observed that the higher the number of risk alleles, the higher the average BMI (Figure 1) and waist circumference (not shown), reaching statistically significant results (with a increase of B±SE: 0.16±0.05 kg/m2; P = 0.001, per-variant allele for BMI and B±SE: 0.43±0.13 cm; P = 0.001, per-variant allele for waist circumference in the adjusted model). Likewise, on considering the aggregate score variable a statistically significant association with obesity was found. In the fully adjusted model (sex, age, center, diabetes, total energy intake and physical activity, each variant allele (FTO or MC4R) of the additive score increased the odds of obesity by 7% (OR = 1.07; 95%CI: 1.01–1.13) for the continuous aggregate score variable).
Multivariate adjusted means. Error bars: SE of means. 0 points (non-variant alleles); 1 point (one variant allele either at FTO or MC4R; 2 points (two variant alleles), 3 points (3 variant alleles) and 4 points (4 variant alleles). P1: unadjusted P-value for the comparison of means; P2: adjusted for sex, age, center, diabetes, energy intake and physical activity.
Gene-physical Activity Interaction between the FTO rs9939609 and MC4R rs17782313 Polymorphisms on Determining Anthropometric Variables
We found a relevant statistically significant interaction between the FTO rs9939609 polymorphism and leisure time physical activity on BMI (P-interaction = 0.010) that remained statistically significant (P-interaction = 0.015) in the multivariate adjusted model (Figure S1A). Thus, in subjects with high leisure time physical activity (higher than the sample mean, 230 kcal/d) we did not detect a statistical significant association between the FTO polymorphism and BMI (mean±SE: 29.5±0.1 kg/m2 in TT, 29.3±0.1 kg/m2 in TA and 29.5±0.2 kg/m2 in AA; P = 0.689). However, when physical activity was low, we did find a significant association between the FTO rs9939609 variant allele and higher BMI (mean±SE: 29.9±0.1 kg/m2 in TT, 30.3±0.1 kg/m2 in TA and 30.7±0.2 kg/m2 in AA; P = 0.001). Likewise, a similar statistically significant interaction (P-interaction = 0.005 in the fully adjusted model) was observed for waist circumference (Figure S1B). Thus, when physical activity was high (higher than the sample mean) we did not detect a statistically significant association between the FTO polymorphism and waist circumference (mean±SE: 99.5±0.4 cm in TT, 99.6±0.3 cm in TA and 99.4±0.5 cm in AA; P = 0.737). However, when physical activity was low, we did find a significant association between the FTO rs9939609 variant allele and higher waist circumference (mean±SE: 100.2±0.4 cm in TT, 101.1±0.3 cm in TA and 102.3±0.5 cm in AA; P<0.001). Despite not finding a similar interaction between the MC4R polymorphism and physical activity in determining anthropometric variables (P-interaction = 0.485 for BMI and P-interaction = 0.151 for waist circumference), we found a statistically significant interaction between physical activity and the aggregate score of both polymorphisms on both BMI (P-interaction = 0.026) (Figure 2A) and waist circumference (P-interaction = 0.014) (Figure 2B).
Adjusted means (n = 7,019) of BMI or waist circumference depending on the aggregate score (0, 1, 2, 3 or 4 variant alleles) according to the strata of physical activity (below and above 230 kcal/d). Means were adjusted for sex, age, center, diabetes and total energy intake. P values for the interaction terms were multivariate adjusted. In the stratified analysis by physical activity, P values for mean comparisons between genotypes in the low (P1) and high strata (P2) were multivariate adjusted. Error bars: SE of means.
On considering obesity (Table 3) we also found a statistically significant interaction between physical activity and the FTO polymorphism (P-interaction = 0.007 for linear allelic effects), that was more significant when the aggregate genetic score variable was analyzed (P-interaction = 0.005 for lineal allelic effects). This interaction effect was clinically relevant as the magnitude of the association was different between the strata. Thus, when physical activity was low, the FTO polymorphism and the aggregate score were significantly associated with higher obesity risk in carriers of the variant allele (a 17% per-allele increase; 95%CI: 7–27 and a 12% per-allele increase; 95%CI: 5–20 in the OR of obesity, respectively). However, when physical activity was high, the FTO polymorphism or the aggregate score were not associated with higher odds of obesity (P = 0.956 and P = 0.376, respectively), suggesting that a high level of physical activity is likely to overcome the detrimental effects of genetic predisposition to obesity even in a high-risk population. This observation was not due to a lack of power to detect statistically significant differences in the stratum of high physical activity for which similar effects than for the low strata were detectable, but the magnitude of the OR was very low and even in the opposite direction (lower than 1).
Gene-diet Interactions between the FTO rs9939609 and MC4R rs17782313 Polymorphisms in Determining Anthropometric Variables
For the FTO polymorphism we did not find statistically significant interactions with the MedDiet on BMI (P-interaction = 0.614) or on waist circumference (P-interaction = 0.229), but the results obtained are compatible with the so-called “biological interaction”. That is to say the FTO polymorphism does not present genetic determinism on BMI or waist circumference. Homozygous subjects for the risk-allele may have higher or lower BMI or waist circumference depending on their greater (above the sample mean: 9 points) or lesser adherence to the MedDiet (Figure S2A and S2B). Hence, AA subjects (homozygous for the obesity risk allele) with low adherence to the MedDiet had a statistically significant higher BMI than AA individuals with high adherence (mean±SE: 30.5±0.2 kg/m2 vs 29.7±0.2 kg/m2, respectively; P = 0.008 in the adjusted model). Likewise, mean waist circumference was statistically higher in AA subjects with low adherence to the MedDiet in comparison with AA subjects with high adherence (mean±SE: 102.5±0.4 cm vs 100.5±0.4 cm, respectively; P = 0.001 in the adjusted model). These effects can be considered clinically relevant in magnitude. Moreover, for waist circumference, higher adherence to the MedDiet significantly reversed the genetic effect. Thus, average waist circumference in AA subjects having high adherence to the MedDiet was significantly lower than average waist circumference in TT subjects with low adherence (mean±SE: 100.4±0.4 cm vs 101.5±0.3 cm, respectively; P = 0.033).
Similar results were observed when analyzing the aggregate score of both polymorphisms on BMI (Figure 3A) or waist circumference (Figure 3B). Although we did not obtain statistically significant interactions between adherence to the MedDiet and the aggregate score on BMI (P-interaction = 0.844) or on waist circumference (P-interaction = 0.981), we observed a “biological interaction”. Despite we did not find statistically significant differences in the slopes of the aggregate score in the two strata of adherence to MedDiet (B1∶0.19; 95%CI: 0.05–0.34 in the low strata vs B2∶0.16; 95%CI: 0.02–0.29 in the high strata) and the B1/B2 ratio was <1.2 (absence of a statistically significant interaction), we clearly observed that the BMI of individuals with higher genetic risk will depend on their greater o lesser adherence to the MedDiet (“biological interaction”). Carriers of 3 or 4 variant alleles had significantly higher BMI when adherence to the MedDiet was low in comparison with their counterparts having a higher adherence (mean±SE: 30.6±0.2 vs 29.8±0.2 kg/m2, respectively; P = 0.021). Interestingly, high adherence to the MedDiet in individuals genetically susceptible (carriers of 4 or 3 variant alleles) counterbalanced their genetic predisposition to higher BMI, exhibiting similar average BMI than individuals with no risk alleles and lower adherence to the MedDiet (mean±SE: 29.8±0.2 vs 30.0±0.2 kg/m2, respectively; P = 0.502). For waist circumference we observed similar results. Carriers of 3 or 4 variant alleles had significantly higher waist circumference than their counterparts when adherence to the MedDiet was low vs high (mean±SE: 102.3±0.6 vs 100.7±0.5 cm, respectively; P = 0.038).
Adjusted means (n = 7,052) according and to the strata of AdMedDiet (below and above 9 points). Means were adjusted for sex, age, center, diabetes, total energy intake and physical activity. P values for the interaction terms were multivariate adjusted. In the stratified analysis by AdMedDiet, P values for mean comparisons of BMI or waist circumference between genotypes were multivariate adjusted (P1 for the low AdMedDiet and P2 for high). Error bars: SE of means.
Association between the FTO rs9939609 and MC4R rs17782313 and Alcohol and Food Intake
We did not observe any significant association between the FTO or the MC4R polymorphisms and food intake (Table S1). Interestingly we found statistically significant associations between both polymorphism and total alcohol intake as well as with wine or beer (lower alcohol consumption in subjects carrying the variant alleles). On analyzing the aggregate score variable (Table 4), we did not obtain statistically significant associations with energy, macronutrients or food groups, however the association with alcohol consumption was higher and remained statistically significant even after multivariate adjustment for sex, age, center, diabetes, total energy intake, physical activity and adherence to the MedDiet (Figure 4A). Moreover, it remained statistically significant even after adjustment for BMI (B = −0.57 g/d per-variant allele; 95%CI: −0.89, −0.25). Per types of alcoholic beverages, we obtained similar results (less consumption in carriers of the variant alleles) for the most consumed alcoholic beverages in this population (wine and beer). Interestingly, when instead of considering alcohol consumption in g/d, we considered subjects as or non-drinkers or drinkers (moderate or high consumption), we also obtained a statistical significant association between the aggregate score and drinking habits. Thus, for the whole population, the prevalence of non-drinkers was higher in subjects with 4 variant alleles in comparison with the prevalence of non-drinkers in subjects with zero variant alleles (43.4% vs 36.5%, respectively; P-trend = 0.01). Likewise, prevalence of subject with high-alcohol consumption was higher in subjects with zero variant alleles (14.5%) than in those with 4 variant alleles (5.7%); P-trend = 0.01). These results were more relevant in men (Figure 4B), in which alcohol consumption was higher than in women. Thus, prevalence of non-drinkers was 28.6% in subjects with 4 variant alleles (vs 15.1% in non-variant allele carriers), and prevalence of men with high-alcohol consumption was 27% in non-drinkers (vs 14.3% in men with 4 variant alleles). These differences can be considered clinically relevant.
Multivariate adjusted means of alcohol consumption depending on the genetic score of both polymorphisms (A) for the whole population (n = 7,019) or drinking categories (B) in men (n = 2,995). P1: unadjusted; P2: adjusted for sex, age, center, diabetes, total energy intake and physical activity. Error bars: SE of means.
Although the magnitude of the effect in the whole sample was lower that that reported for the general population , in this study undertaken in elderly subjects we have found that the FTO rs9939609 polymorphism was significantly associated with higher BMI, waist circumference and obesity prevalence, our results coinciding with previous investigations , –. However, the MC4R rs17782313 polymorphism did not reach the statistical significance as it had a lesser effect in this population and, even though a similar trend was observed. While several studies have reported statistically significant associations between the MC4R rs17782313 and BMI or obesity , , , , there are also studies that did not find a significant association ,  or found stronger associations with weight than BMI  and even studies that have reported an association with higher height , ,  and that this association may mask the effects on BMI despite being associated with higher weight. Our results are in agreement with this observation as we found statistically significant differences in weight and height (although very small in magnitude for height).In agreement with other studies ,  we have also found additive effects of these polymorphisms in this population. We observed that the aggregate score of both was associated with higher BMI, waist circumference and obesity prevalence with higher statistical significance and higher magnitude of the effect than the independent polymorphisms.
Interestingly, the magnitude of effects of the FTO and MC4R polymorphisms were not homogeneous in the whole population. Regarding interactions of these polymorphisms with lifestyle variables, many studies have analyzed the statistical interaction of the FTO polymorphism with physical activity obtaining some different results depending on the population , , , , , , , . However, a recent meta-analysis including 218,166 adults and 19,268 children  concluded that there was a consistent statistically significant interaction between the FTO rs9939609 polymorphism and physical activity on obesity risk. Thus, in sedentary subjects the association of the FTO polymorphisms with higher BMI or obesity risk was greater in magnitude than in active subjects. In agreement with these results, we also found a consistent statistically significant interaction between the FTO rs9939609 polymorphism and leisure time physical activity in determining BMI, waist circumference and obesity prevalence, so that the association between the FTO-risk allele and higher BMI or obesity prevalence disappeared in active subjects and was increased in magnitude of the effect and clinical significance in subjects with low physical activity. We did not find any significant interaction between physical activity and the MC4R rs17782313 on BMI, waist circumference or obesity, but observed a similar trend. A lack of power to detect the statistical significance was identified for the MC4R polymorphism taking into account the lower prevalence of the risk-allele and the lower magnitude of the effect of this polymorphism. However, on considering the aggregate score of the MC4R rs17782313 and FTO rs9939609, we did observe a statistically significant interaction both for BMI and for obesity. As far as we know this is the first time that a statistically significant interaction between the aggregate score of the FTO and the MC4R polymorphisms and physical activity on BMI and obesity is reported. Moreover, the magnitude of the effect of this interaction was strong and can be considered as clinically relevant.
With regard to the modulation of the effects of these polymorphisms by diet, there are few studies that have analyzed it in comparison with physical activity, and the consistency level is still low , , –, , , . Sonestedt et al  reported a statistically significant interaction between diet and the FTO rs9939609 polymorphism on BMI and found that a high total fat and a low carbohydrate intake boosted the effects of this polymorphism. In another study , we concluded that saturated fatty acids were those that presented a more statistically significant and clinically relevant interaction with the FTO polymorphism in determining BMI in two American populations. Phillips et al  also found a significant interaction with saturated fat intake, replicating our previous findings. However, Vimaleswaran et al , analyzing data from five European countries reported no statistically significant interaction between the FTO rs9939609 and dietary fat, protein or carbohydrate on BMI. Regarding the MC4R rs17782313, the number of studies examining gene-diet interactions on anthropometric variables is very scarce . Qi et al  reported no significant interactions between the MC4R rs17782313 polymorphism and dietary intake on BMI in The Nurses’ Health Study. In our Mediterranean population we did not find a statistically significant interaction of the FTO rs9939609 or the MC4R rs17782313 polymorphisms with either total fat or saturated fat intake (data not shown). This is possible due to the fact that we were dealing with a high overall adherence to the MedDiet population in which in general there is a low saturated fat intake and a high MUFA intake from olive oil. We hypothesized that the low or high adherence to the overall MedDiet pattern will be more important than the effect of specific macronutrients. However, when we analyzed the interaction between the adherence to the MedDiet and these polymorphisms on anthropometric variables, we did not find statistically significant gene-diet interactions. The P-values for the interaction terms were non-statistically significant because the effect of the polymorphisms were present (statistically significant) both in the low and the high strata of MedDiet adherence [parallel lines (B1 = B2) in Figure 3]. This was not due to a lack of power to detect the interaction term as statistically significant but to a true absence of heterogeneity of genetic effects between the strata. However, as the MedDiet has also a statistically significant effect on reducing BMI (P<0.05), we observed statistically significant differences between the genotypes depending on the adherence to the MedDiet. We believe that it is important to stress that these observed results are compatible with the so-called “biological gene-diet interaction” , . A biological gene-environment interaction situation takes place when there is an environmental factor capable of modifying genetic susceptibility and it is independent of the statistical significance , . This biological interaction is opposed to the genetic determinism, in which the genotype completely determines the phenotype. In the genetic determinism situation, if a subject is a carrier of the risk alleles of the FTO and the MC4R polymorphisms, such genetic susceptibility would irreversibly determine the obesity phenotype, and that genetic influence would be totally independent of lifestyle factors. However, no genetic determinism will occur when dietary modulation exists (in this case higher adherence to the MedDiet) that could modify genetic susceptibility (greater BMI in variant allele carriers) without the interaction term in the mathematical model being statistically significant. Supporting our cross-sectional results, there is an interventional study carried out in a small sub-sample of the PREDIMED participants  showing that after 3 years of nutritional intervention with MedDiet, A-allele carriers for the FTO rs9939609 had lower body weight gain than TT subjects. Therefore, it seems important to reconsider the concept of gene-diet interaction and not to discard the potential use of other “biological interactions” that could modify genetic susceptibility without the interaction term in the mathematical model being statistically significant –, .
Regarding dietary intake, we did not find a consistent association of the FTO or the MC4R polymorphisms with total energy, fat, carbohydrates o protein intake, in agreement with other studies –, . However, we do wish to stress the finding of an important association with alcohol consumption. We have observed that carriers of the variant allele, both for the FTO rs9939609 and the MC4R rs17782313 polymorphisms had statistically significant lower alcohol consumption than wild-type subjects. The magnitude of this effect was higher for the aggregate score and remained statistically significant even after adjustment for BMI. There are no previous studies on humans that have reported an association of the MC4R s17782313 polymorphism with alcohol intake although there are several studies on animals which indicate the great importance of the MC4R in determining alcohol intake –. Among them, the work carried out by Navarro et al , showing that in mice, when given centrally a melanocortin receptor agonist, melanotan-II reduced ethanol drinking by signalling through the MC4R and suggested that this association is independent of food intake. Therefore our results of the association between the MC4R polymorphism and alcohol intake are novel in humans and mechanistically supported by results in mice –. With regard to FTO some studies have analyzed the influence of alcohol intake in humans with varying results , . Among them we could mention a study carried out in Poland  that, in agreement with our results, also found a lower alcohol intake in carriers of the variant allele of the FTO rs9939609 polymorphism .
One limitation in our study may be that we have used self-reported measures of diet and physical activity in place of 24-hour record of food intake for diet pedometers or accelerometers that are more objective measures. However, taking into account our large sample size this was not possible due to the high cost that this would involve. Moreover, we have specifically validated the semi-quantitative 137-item food frequency questionnaire  as well as the MedDiet adherence questionnaire in this specific population obtaining excellent results . On the other hand, the Minnesota Leisure Time Physical Activity Questionnaire used to measure physical activity as also validated in men  and women  from the Spanish population.
In conclusion, we have confirmed the association of the FTO rs9939609 polymorphism with higher BMI, waist circumference and obesity even in a high cardiovascular risk population and described an additive effect of the FTO rs9939609 and the MC4R rs17782313 on these obesity-related measures. Moreover, we have found that these genetic effects can be modulated by lifestyle variables, the statistical interaction with physical activity and the biological interaction (not statistically significant) with the adherence to the MedDiet being especially important in magnitude. Although in this population the FTO and the MC4R polymorphisms do not have a relevant association with food intake, their association with alcohol consumption is outstanding. This is the first time that an association of both polymorphisms with alcohol intake in humans is reported, although there are important data supporting the influence of the MC4R in alcohol intake in animal models. More studies are needed to replicate and extend these findings.
Statistical interaction between the FTO rs9939609 polymorphism and physical activity (PA) in determining BMI (A) or waist circumference (B). Adjusted means (n = 7,052) of BMI or waist circumference depending on the FTO genotypes according to the strata of physical activity (below and above 230 kcal/d). Means were adjusted for sex, age, center, diabetes and total energy intake. P values for the interaction terms were multivariate adjusted. In the stratified analysis by physical activity, P values for mean comparisons between genotypes in the low (P1) and high strata (P2) were multivariate adjusted. Error bars: SE of means.
Interaction between the FTO rs9939609 and adherence to the Mediterranean Diet (AdMedDiet) on BMI (A) or waist circumference (B). Adjusted means (n = 7,052) of BMI or waist circumference according to the strata of AdMedDiet (below and above 9 points). Means were adjusted for sex, age, field center, diabetes, total energy intake and physical activity. P values for the interaction terms and for mean comparisons between homozygous subjects for the variant allele were multivariate adjusted. Error bars: SE of means.
Conceived and designed the experiments: DC COA JVS RE. Performed the experiments: DC COA JVS RE PC. Analyzed the data: DC JVS COA RE. Contributed reagents/materials/analysis tools: DC COA JVS RE PC MAM JMO OC JSS MIC FA JL XP ER EGG AM RLR LLSM MF. Wrote the paper: DC JVS JMO. Corrected the paper, JMO OC RE.
- 1. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, et al. (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316: 889–94.
- 2. Loos RJ, Lindgren CM, Li S, Wheeler E, Zhao JH, et al. (2008) Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 40: 768–75.
- 3. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, et al. (2003) Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 348: 1085–95.
- 4. Loos RJ (2011) The genetic epidemiology of melanocortin 4 receptor variants. Eur J Pharmacol 660: 156–64.
- 5. Peng S, Zhu Y, Xu F, Ren X, Li X, et al. (2011) FTO gene polymorphisms and obesity risk: a meta-analysis. BMC Med 9: 71.
- 6. Li H, Kilpeläinen TO, Liu C, Zhu J, Liu Y, et al. (2012) Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia 55: 981–95.
- 7. Hertel JK, Johansson S, Sonestedt E, Jonsson A, Lie RT, et al. (2011) FTO, type 2 diabetes, and weight gain throughout adult life: a meta-analysis of 41,504 subjects from the Scandinavian HUNT, MDC, and MPP studies. Diabetes 60: 1637–44.
- 8. Corella D, Carrasco P, Sorlí JV, Coltell O, Ortega-Azorín C, et al. (2012) Education modulates the association of the FTO rs9939609 polymorphism with body mass index and obesity risk in the Mediterranean population. Nutr Metab Cardiovasc Dis 22: 651–8.
- 9. Vasan SK, Fall T, Neville MJ, Antonisamy B, Fall CH, et al.. (2012) Associations of Variants in FTO and Near MC4R With Obesity Traits in South Asian Indians. Obesity (Silver Spring) e-publication ahead of print.
- 10. Rouskas K, Kouvatsi A, Paletas K, Papazoglou D, Tsapas A, et al. (2012) Common variants in FTO, MC4R, TMEM18, PRL, AIF1, and PCSK1 show evidence of association with adult obesity in the Greek population. Obesity (Silver Spring) 20: 389–95.
- 11. Hardy R, Wills AK, Wong A, Elks CE, Wareham NJ, et al. (2010) Life course variations in the associations between FTO and MC4R gene variants and body size. Hum Mol Genet 19: 545–52.
- 12. Cauchi S, Stutzmann F, Cavalcanti-Proença C, Durand E, Pouta A, et al. (2009) Combined effects of MC4R and FTO common genetic variants on obesity in European general populations. J Mol Med (Berl) 87: 537–46.
- 13. Huang W, Sun Y, Sun J (2011) Combined effects of FTO rs9939609 and MC4R rs17782313 on obesity and BMI in Chinese Han populations. Endocrine 39: 69–74.
- 14. Church C, Moir L, McMurray F, Girard C, Banks GT, et al. (2010) Overexpression of Fto leads to increased food intake and results in obesity. Nat Genet 42: 1086–92.
- 15. Tung YC, Ayuso E, Shan X, Bosch F, O’Rahilly S, et al. (2010) Hypothalamic-specific manipulation of Fto, the ortholog of the human obesity gene FTO, affects food intake in rats. PLoS One 5: e8771.
- 16. Srisai D, Gillum MP, Panaro BL, Zhang XM, Kotchabhakdi N, et al. (2011) Characterization of the hyperphagic response to dietary fat in the MC4R knockout mouse. Endocrinology 152: 890–902.
- 17. Cecil JE, Tavendale R, Watt P, Hetherington MM, Palmer CN (2008) An obesity-associated FTO gene variant and increased energy intake in children. N Engl J Med 359: 2558–66.
- 18. Timpson NJ, Emmett PM, Frayling TM, Rogers I, Hattersley AT, et al. (2008) The fat mass- and obesity-associated locus and dietary intake in children. Am J Clin Nutr 88: 971–8.
- 19. Haupt A, Thamer C, Staiger H, Tschritter O, Kirchhoff K, et al. (2009) Variation in the FTO gene influences food intake but not energy expenditure. Exp Clin Endocrinol Diabetes 117: 194–7.
- 20. Hakanen M, Raitakari OT, Lehtimäki T, Peltonen N, Pahkala K, et al. (2009) FTO genotype is associated with body mass index after the age of seven years but not with energy intake or leisure-time physical activity. J Clin Endocrinol Metab 94: 1281–7.
- 21. Liu G, Zhu H, Lagou V, Gutin B, Stallmann-Jorgensen IS, et al. (2010) FTO variant rs9939609 is associated with body mass index and waist circumference, but not with energy intake or physical activity in European- and African-American youth. BMC Med Genet 11: 57.
- 22. Corella D, Arnett DK, Tucker KL, Kabagambe EK, Tsai M, et al. (2011) A high intake of saturated fatty acids strengthens the association between the fat mass and obesity-associated gene and BMI. J Nutr 141: 2219–25.
- 23. Hasselbalch AL, Angquist L, Christiansen L, Heitmann BL, Kyvik KO, et al. (2010) A variant in the fat mass and obesity-associated gene (FTO) and variants near the melanocortin-4 receptor gene (MC4R) do not influence dietary intake. J Nutr 140: 831–4.
- 24. Qi L, Kraft P, Hunter DJ, Hu FB (2008) The common obesity variant near MC4R gene is associated with higher intakes of total energy and dietary fat, weight change and diabetes risk in women. Hum Mol Genet 17: 3502–8.
- 25. Tenesa A, Campbell H, Theodoratou E, Dunlop L, Cetnarskyj R, et al. (2009) Common genetic variants at the MC4R locus are associated with obesity, but not with dietary energy intake or colorectal cancer in the Scottish population. Int J Obes (Lond) 33: 284–8.
- 26. Cole SA, Butte NF, Voruganti VS, Cai G, Haack K, et al. (2010) Evidence that multiple genetic variants of MC4R play a functional role in the regulation of energy expenditure and appetite in Hispanic children. Am J Clin Nutr 91: 191–9.
- 27. Andreasen CH, Stender-Petersen KL, Mogensen MS, Torekov SS, Wegner L, et al. (2008) Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation. Diabetes 57: 95–101.
- 28. Rampersaud E, Mitchell BD, Pollin TI, Fu M, Shen H, et al. (2008) Physical activity and the association of common FTO gene variants with body mass index and obesity. Arch Intern Med 168: 1791–7.
- 29. Kilpeläinen TO, Qi L, Brage S, Sharp SJ, Sonestedt E, et al. (2011) Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med 8: e1001116.
- 30. Xi B, Wang C, Wu L, Zhang M, Shen Y, et al. (2011) Influence of physical inactivity on associations between single nucleotide polymorphisms and genetic predisposition to childhood obesity. Am J Epidemiol 173: 1256–62.
- 31. Liem ET, Vonk JM, Sauer PJ, van der Steege G, Oosterom E, et al. (2010) Influence of common variants near INSIG2, in FTO, and near MC4R genes on overweight and the metabolic profile in adolescence: the TRAILS (TRacking Adolescents’ Individual Lives Survey) Study. Am J Clin Nutr 91: 321–8.
- 32. Sonestedt E, Roos C, Gullberg B, Ericson U, Wirfält E, et al. (2009) Fat and carbohydrate intake modify the association between genetic variation in the FTO genotype and obesity. Am J Clin Nutr 90: 1418–25.
- 33. Vimaleswaran KS, Angquist L, Hansen RD, van der A DL, Bouatia-Naji N, et al. (2012) Association Between FTO Variant and Change in Body Weight and Its Interaction With Dietary Factors: The DiOGenes Study. Obesity (Silver Spring) 20: 1669–74.
- 34. Lappalainen T, Lindström J, Paananen J, Eriksson JG, Karhunen L, et al. (2012) Association of the fat mass and obesity-associated (FTO) gene variant (rs9939609) with dietary intake in the Finnish Diabetes Prevention Study. Br J Nutr 23: 1–7.
- 35. Phillips CM, Kesse-Guyot E, McManus R, Hercberg S, Lairon D, et al. (2012) High dietary saturated fat intake accentuates obesity risk associated with the fat mass and obesity-associated gene in adults. J Nutr 142: 824–31.
- 36. Wang X, Elston RC, Zhu X (2010) The meaning of interaction. Hum Hered 70: 269–77.
- 37. Ahlbom A, Alfredsson L (2005) Interaction: A word with two meanings creates confusion. Eur J Epidemiol 20: 563–4.
- 38. Corella D, Ordovas JM (2009) Nutrigenomics in cardiovascular medicine. Circ Cardiovasc Genet 2: 637–51.
- 39. Dempfle A, Scherag A, Hein R, Beckmann L, Chang-Claude J, et al. (2008) Gene-environment interactions for complex traits: definitions, methodological requirements and challenges. Eur J Hum Genet (16): 1164–72.
- 40. Estruch R, Martínez-González MA, Corella D, Salas-Salvadó J, Ruiz-Gutiérrez V, et al. (2006) Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 145: 1–11.
- 41. Martínez-González MA, Corella D, Salas-Salvadó J, Ros E, Covas MI, et al. (2012) Cohort Profile: Design and methods of the PREDIMED study. Int J Epidemiol 41: 377–385.
- 42. American Diabetes Association (2008) Diagnosis and classification of diabetes mellitus. Diabetes Care 31: S55–S60.
- 43. Fernández-Ballart JD, Piñol JL, Zazpe I, Corella D, Carrasco P, et al. (2010) Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of Spain. Br J Nutr 103: 1808–16.
- 44. Mataix J (2003) Tabla de composición de alimentos (Food composition tables). 4th ed. Granada: Universidad de Granada.
- 45. Pearson TA (1996) Alcohol and heart disease. Circulation 94: 3023–3025.
- 46. Schröder H, Fitó M, Estruch R, Martínez-González MA, Corella D, et al. (2011) A short screener is valid for assessing Mediterranean diet adherence among older Spanish men and women. J Nutr 141: 1140–5.
- 47. Elosua R, Marrugat J, Molina L, Pons S, Pujol E (1994) On behalf of investigators of the MARATDON Group. Validation of the Minessota Leisure time physical activity questionnaire in Spanish men. J Epidemiol 139: 1197–09.
- 48. Elosua R, Garcia M, Aguilar A, Molina L, Covas MI, et al. (2000) Validation of the Minnesota Leisure time physical activity questionnaire in Spanish women. Med Sci Sports Exerc 32: 1431–37.
- 49. Gauderman WJ, Morrison JM (2006) QUANTO 1.1: A computer program for power and sample size calculations for gene-epidemiology studies. Available. http://hydra.usc.edu/gxe.
- 50. Luan JA, Wong MY, Day NE, Wareham NJ (2001) Sample size determination for studies of gene-environment interaction. Int J Epidemiol 30: 1035–40.
- 51. Thomsen M, Dahl M, Tybjærg-Hansen A, Nordestgaard BG (2012) β2-Adrenergic Receptor Thr164Ile Polymorphism, Obesity, and Diabetes: Comparison with FTO, MC4R, and TMEM18 Polymorphisms in More Than 64,000 Individuals. J Clin Endocrinol Metab 97: E1074–9.
- 52. Liu G, Zhu H, Dong Y, Podolsky RH, Treiber FA, et al. (2011) Influence of common variants in FTO and near INSIG2 and MC4R on growth curves for adiposity in African- and European-American youth. Eur J Epidemiol 26: 463–73.
- 53. Santoro N, Cirillo G, Xiang Z, Tanas R, Greggio N, et al. (2009) Prevalence of pathogenetic MC4R mutations in Italian children with early onset obesity, tall stature and familial history of obesity. BMC Med Genet 10: 25.
- 54. Martinelli CE, Keogh JM, Greenfield JR, Henning E, van der Klaauw AA, et al. (2011) Obesity due to melanocortin 4 receptor (MC4R) deficiency is associated with increased linear growth and final height, fasting hyperinsulinemia, and incompletely suppressed growth hormone secretion. J Clin Endocrinol Metab 96: E181–8.
- 55. Taylor AE, Sandeep MN, Janipalli CS, Giambartolomei C, Evans DM, et al.. (2011). Associations of FTO and MC4R Variants with Obesity Traits in Indians and the Role of Rural/Urban Environment as a Possible Effect Modifier. J Obes :307542.
- 56. Razquin C, Martinez JA, Martinez-Gonzalez MA, Bes-Rastrollo M, Fernández-Crehuet J, et al. (2010) A 3-year intervention with a Mediterranean diet modified the association between the rs9939609 gene variant in FTO and body weight changes. Int Obes (Lond). 2010 34: 266–72.
- 57. Baik I, Shin C (2012) Interactions between the FTO rs9939609 polymorphism, body mass index, and lifestyle-related factors on metabolic syndrome risk. Nutr Res Pract. 6: 78–85.
- 58. Grau K, Hansen T, Holst C, Astrup A, Saris WH, et al. (2009) Macronutrient-specific effect of FTO rs9939609 in response to a 10-week randomized hypo-energetic diet among obese Europeans. Int J Obes (Lond). 33: 1227–34.
- 59. Wang X, Elston RC, Zhu X (2011) Statistical interaction in human genetics: how should we model it if we are looking for biological interaction? Nat Rev Genet 12: 74.
- 60. Navarro M, Cubero I, Chen AS, Chen HY, Knapp DJ, et al. (2005) Effects of melanocortin receptor activation and blockade on ethanol intake: a possible role for the melanocortin-4 receptor. Alcohol Clin Exp Res 29: 949–57.
- 61. Navarro M, Lerma-Cabrera JM, Carvajal F, Lowery EG, Cubero I, et al. (2011) Assessment of voluntary ethanol consumption and the effects of a melanocortin (MC) receptor agonist on ethanol intake in mutant C57BL/6J mice lacking the MC-4 receptor. Alcohol Clin Exp Res 35: 1058–66.
- 62. Polidori C, Geary N, Massi M (2006) Effect of the melanocortin receptor stimulation or inhibition on ethanol intake in alcohol-preferring rats. Peptides 27: 144–9.
- 63. York DA, Boghossian S, Park-York M (2011) Melanocortin activity in the amygdala influences alcohol intake. Pharmacol Biochem Behav 98: 112–9.
- 64. Nordestgaard BG, Palmer TM, Benn M, Zacho J, Tybjaerg-Hansen A, et al. (2012) The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a mendelian randomisation approach. PLoS Med 9: e1001212.
- 65. Sobczyk-Kopciol A, Broda G, Wojnar M, Kurjata P, Jakubczyk A, et al. (2011) Inverse association of the obesity predisposing FTO rs9939609 genotype with alcohol consumption and risk for alcohol dependence. Addiction 106: 739–48.